Insider Buying: STAAR Surgical (NASDAQ:STAA) Major Shareholder Purchases $1,633,394.96 in Stock

STAAR Surgical (NASDAQ:STAA) major shareholder Broadwood Partners, L.P. bought 93,124 shares of the business’s stock in a transaction that occurred on Tuesday, March 18th. The shares were acquired at an average price of $17.54 per share, for a total transaction of $1,633,394.96. Following the transaction, the insider now owns 12,074,275 shares in the company, valued at $211,782,783.50. This represents a 0.78 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Broadwood Partners, L.P. also recently made the following trade(s):

• On Thursday, March 20th, Broadwood Partners, L.P. purchased 108,720 shares of STAAR Surgical stock. The stock was acquired at an average cost of $17.96 per share, for a total transaction of $1,952,611.20.
• On Monday, March 3rd, Broadwood Partners, L.P. acquired 249,503 shares of STAAR Surgical stock. The shares were bought at an average cost of $16.64 per share, with a total value of $4,151,729.92.
• On Thursday, February 27th, Broadwood Partners, L.P. acquired 259,316 shares of STAAR Surgical stock. The stock was bought at an average price of $17.05 per share, with a total value of $4,421,337.80.
• On Friday, February 14th, Broadwood Partners, L.P. bought 36,532 shares of STAAR Surgical stock. The shares were bought at an average cost of $15.49 per share, for a total transaction of $565,880.68.
• On Wednesday, February 12th, Broadwood Partners, L.P. purchased 259,616 shares of STAAR Surgical stock. The stock was bought at an average cost of $14.96 per share, with a total value of $3,883,855.36.
• On Thursday, January 16th, Broadwood Partners, L.P. acquired 8,221 shares of STAAR Surgical stock. The shares were bought at an average cost of $21.50 per share, for a total transaction of $176,751.50.
• On Tuesday, January 14th, Broadwood Partners, L.P. bought 21,155 shares of STAAR Surgical stock. The stock was purchased at an average cost of $21.46 per share, with a total value of $453,986.30.

STAAR Surgical Stock Performance

Shares of STAA stock opened at $17.72 on Friday. The company has a market capitalization of $874.04 million, a price-to-earnings ratio of -43.22 and a beta of 0.66. STAAR Surgical has a 52-week low of $13.50 and a 52-week high of $52.68. The company has a 50-day simple moving average of $19.87 and a two-hundred day simple moving average of $25.66.

Analysts Set New Price Targets

Several equities research analysts have recently commented on STAA shares. Needham & Company LLC restated a “hold” rating on shares of STAAR Surgical in a report on Thursday, February 27th. BTIG Research downgraded shares of STAAR Surgical from a “buy” rating to a “neutral” rating in a report on Wednesday, February 12th. Jefferies Financial Group lowered shares of STAAR Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, February 12th. Mizuho downgraded shares of STAAR Surgical from an “outperform” rating to a “neutral” rating and decreased their target price for the stock from $45.00 to $17.00 in a research report on Wednesday, February 12th. Finally, Stephens reaffirmed an “equal weight” rating and issued a $17.00 price target on shares of STAAR Surgical in a research report on Tuesday, March 18th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $25.29.

Hedge Funds Weigh In On STAAR Surgical

Several institutional investors have recently modified their holdings of STAA. Quarry LP bought a new stake in STAAR Surgical during the third quarter worth $50,000. Quest Partners LLC bought a new stake in shares of STAAR Surgical during the 3rd quarter worth $128,000. Larson Financial Group LLC boosted its holdings in shares of STAAR Surgical by 78.3% in the 3rd quarter. Larson Financial Group LLC now owns 4,863 shares of the medical instruments supplier’s stock worth $181,000 after buying an additional 2,135 shares during the last quarter. FMR LLC grew its position in STAAR Surgical by 79.3% during the third quarter. FMR LLC now owns 7,092 shares of the medical instruments supplier’s stock valued at $263,000 after buying an additional 3,136 shares during the period. Finally, KLP Kapitalforvaltning AS purchased a new stake in STAAR Surgical during the fourth quarter worth about $180,000. 96.70% of the stock is owned by institutional investors.

STAAR Surgical Company Profile

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.